Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut ZNF827 152485 broad.mit.edu 37 4 146813423 146813423 + Missense_Mutation SNP C C T TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr4:146813423C>T ENST00000508784.1 - 3 1465 c.1238G>A c.(1237-1239)cGc>cAc p.R413H ZNF827_ENST00000379448.4_Missense_Mutation_p.R413H|ZNF827_ENST00000513320.1_Missense_Mutation_p.R63H Q17R98 ZN827_HUMAN zinc finger protein 827 413 regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding|zinc ion binding NS(1)|breast(2)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(13)|lung(18)|prostate(4)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1) 48 all_hematologic(180;0.151) ATTGTCCTTGCGAGCACACCG 0.512000 25 82 0 0 0.006320 0 0 CRB1 23418 broad.mit.edu 37 1 197390659 197390659 + Nonsense_Mutation SNP G G A TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr1:197390659G>A ENST00000367400.3 + 6 1836 c.1701G>A c.(1699-1701)tgG>tgA p.W567* CRB1_ENST00000543483.1_Nonsense_Mutation_p.W266*|CRB1_ENST00000367399.2_Nonsense_Mutation_p.W455*|CRB1_ENST00000538660.1_Nonsense_Mutation_p.W567*|CRB1_ENST00000544212.1_Nonsense_Mutation_p.W48*|CRB1_ENST00000367397.1_5'UTR|CRB1_ENST00000535699.1_Nonsense_Mutation_p.W498* NM_201253.2 NP_957705.1 P82279 CRUM1_HUMAN crumbs homolog 1 (Drosophila) 567 Laminin G-like 1. cell-cell signaling|establishment or maintenance of cell polarity apical plasma membrane|extracellular region|integral to membrane calcium ion binding|protein binding NS(1)|breast(4)|central_nervous_system(2)|cervix(3)|endometrium(13)|kidney(4)|large_intestine(21)|lung(58)|ovary(7)|prostate(3)|skin(10)|upper_aerodigestive_tract(4)|urinary_tract(2) 132 ATGGAGAGTGGCATTTCGTGG 0.458000 4 172 0 0 0.014758 0 0 CAPN9 10753 broad.mit.edu 37 1 230903289 230903289 + Missense_Mutation SNP T T C TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr1:230903289T>C ENST00000354537.1 + 5 621 c.539T>C c.(538-540)cTa>cCa p.L180P RP11-99J16__A.2_ENST00000412344.1_RNA|CAPN9_ENST00000271971.2_Missense_Mutation_p.L180P|CAPN9_ENST00000366666.2_Missense_Mutation_p.L117P NM_016452.1 NP_057536.1 O14815 CAN9_HUMAN calpain 9 180 Calpain catalytic. digestion|proteolysis intracellular calcium ion binding|calcium-dependent cysteine-type endopeptidase activity autonomic_ganglia(1)|breast(1)|endometrium(1)|kidney(1)|large_intestine(2)|lung(12)|ovary(2)|skin(3)|stomach(1)|upper_aerodigestive_tract(1) 25 Breast(184;0.0871)|Ovarian(103;0.183) Prostate(94;0.167) CCTTGCAGGCTAAATGGGAGC 0.567000 3 95 0 0 0.009096 0 0 ACP2 53 broad.mit.edu 37 11 47264838 47264838 + Silent SNP G G A TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr11:47264838G>A ENST00000256997.3 - 8 923 c.807C>T c.(805-807)acC>acT p.T269T ACP2_ENST00000527256.1_Silent_p.T237T|ACP2_ENST00000537863.1_Silent_p.T82T|ACP2_ENST00000533929.1_Silent_p.T241T|ACP2_ENST00000529444.1_Silent_p.T206T|ACP2_ENST00000525230.1_5'UTR NM_001610.2 NP_001601.1 P11117 PPAL_HUMAN acid phosphatase 2, lysosomal 269 integral to membrane|lysosomal lumen|lysosomal membrane acid phosphatase activity breast(1)|endometrium(1)|kidney(1)|large_intestine(3)|lung(2)|ovary(1)|prostate(1) 10 TCGCCATTAGGGTCAGGTTCT 0.562000 6 62 0 0 0.001984 0 0 TRIM7 81786 broad.mit.edu 37 5 180622600 180622600 + Missense_Mutation SNP C C T TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr5:180622600C>T ENST00000393315.1 - 7 1175 c.478G>A c.(478-480)Gag>Aag p.E160K TRIM7_ENST00000393319.3_Missense_Mutation_p.E186K|TRIM7_ENST00000504241.1_5'UTR|CTC-338M12.6_ENST00000512508.1_RNA|TRIM7_ENST00000274773.7_Missense_Mutation_p.E368K|TRIM7_ENST00000422067.2_Missense_Mutation_p.E160K|TRIM7_ENST00000361809.3_Missense_Mutation_p.E160K NM_203296.1 NP_976041.1 Q9C029 TRIM7_HUMAN tripartite motif containing 7 368 cytoplasm|nucleus zinc ion binding NS(1)|cervix(1)|endometrium(2)|large_intestine(3)|lung(6)|ovary(2)|skin(1)|stomach(1) 17 all_cancers(89;6.03e-06)|all_epithelial(37;7.1e-07)|Renal(175;0.000159)|Lung NSC(126;0.00354)|all_lung(126;0.00609)|Breast(19;0.0684) all_cancers(40;0.000172)|Medulloblastoma(196;0.0133)|all_neural(177;0.0199)|all_lung(500;0.0221)|all_hematologic(541;0.0433)|Lung NSC(249;0.132)|Ovarian(839;0.238) Kidney(164;2.23e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178) all cancers(165;2e-06)|Epithelial(171;1.35e-05)|OV - Ovarian serous cystadenocarcinoma(192;0.000128)|Kidney(146;0.0674)|GBM - Glioblastoma multiforme(465;0.0802) TGGGCCCGCTCGCCGAGGCGC 0.667000 20 76 0 0 0.008871 0 0 ANKRD30B 374860 broad.mit.edu 37 18 14843023 14843023 + Splice_Site SNP C C G TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr18:14843023C>G ENST00000358984.4 + 33 2932 c.2751_splice c.e33-1 p.P918_splice NM_001145029.1 NP_001138501.1 Q9BXX2 AN30B_HUMAN ankyrin repeat domain 30B 1003 breast(3)|endometrium(4)|kidney(3)|lung(8)|ovary(1)|prostate(2)|skin(1) 22 ACCCGTTTAGCCTGCCACTGA 0.289000 3 21 0 0 0.004672 0 0 MRGBP 55257 broad.mit.edu 37 20 61428541 61428541 + Silent SNP C C G TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr20:61428541C>G ENST00000370487.3 + 2 299 c.228C>G c.(226-228)gtC>gtG p.V76V NM_018270.4 NP_060740.1 MRG/MORF4L binding protein CATCCAAGGTCATCTGGGACC 0.632000 23 43 0 0 0.014323 0 0 DIXDC1 85458 broad.mit.edu 37 11 111865764 111865764 + Missense_Mutation SNP A A T TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr11:111865764A>T ENST00000440460.2 + 16 1753 c.1456A>T c.(1456-1458)Aac>Tac p.N486Y DIXDC1_ENST00000389821.4_3'UTR|DIXDC1_ENST00000315253.5_Missense_Mutation_p.N275Y NM_001037954.2 NP_001033043.1 Q155Q3 DIXC1_HUMAN DIX domain containing 1 487 multicellular organismal development|positive regulation of canonical Wnt receptor signaling pathway|Wnt receptor signaling pathway cytosol|focal adhesion actin binding|gamma-tubulin binding|signal transducer activity cervix(2)|endometrium(4)|kidney(1)|large_intestine(3)|lung(6)|ovary(1) 17 all_cancers(61;7.58e-15)|all_epithelial(67;5.42e-09)|Melanoma(852;1.91e-06)|all_hematologic(158;0.000405)|Acute lymphoblastic leukemia(157;0.000967)|Breast(348;0.0112)|all_neural(223;0.0281)|Medulloblastoma(222;0.0425) Epithelial(105;2.99e-07)|BRCA - Breast invasive adenocarcinoma(274;6.72e-07)|all cancers(92;6.25e-06)|OV - Ovarian serous cystadenocarcinoma(223;0.0548) CAACAGTCACAACTCTCAAAG 0.438000 79 152 0 0 0.014410 0 0 BOD1L1 259282 broad.mit.edu 37 4 13604944 13604944 + Missense_Mutation SNP C C T TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr4:13604944C>T ENST00000040738.5 - 10 3715 c.3580G>A c.(3580-3582)Gaa>Aaa p.E1194K NM_148894.2 NP_683692.2 Q8NFC6 BOD1L_HUMAN biorientation of chromosomes in cell division 1-like 1 1194 DNA binding GCATGCTTTTCAGAATTACTA 0.428000 9 295 0 0 0.006214 0 0 KIF21B 23046 broad.mit.edu 37 1 200956290 200956290 + Missense_Mutation SNP C C T TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr1:200956290C>T ENST00000332129.2 - 25 3764 c.3448G>A c.(3448-3450)Gct>Act p.A1150T KIF21B_ENST00000360529.5_Missense_Mutation_p.A1150T|KIF21B_ENST00000422435.2_Missense_Mutation_p.A1150T|KIF21B_ENST00000461742.2_Missense_Mutation_p.A1150T NM_001252102.1|NM_001252103.1|NM_017596.3 NP_001239031.1|NP_001239032.1|NP_060066.2 O75037 KI21B_HUMAN kinesin family member 21B 1150 microtubule-based movement cytoplasm|microtubule ATP binding|microtubule motor activity autonomic_ganglia(1)|breast(4)|central_nervous_system(1)|cervix(1)|endometrium(15)|kidney(4)|large_intestine(8)|liver(1)|lung(27)|ovary(3)|pancreas(1)|prostate(5)|skin(8)|stomach(2)|urinary_tract(2) 83 AGGCACTCAGCCGACACAGCT 0.547000 4 202 0 0 0.014758 0 0 RTN2 6253 broad.mit.edu 37 19 45991754 45991754 + Missense_Mutation SNP A A G TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr19:45991754A>G ENST00000590526.1 - 9 1776 c.650T>C c.(649-651)aTc>aCc p.I217T RTN2_ENST00000245923.4_Missense_Mutation_p.I491T|RTN2_ENST00000344680.4_Missense_Mutation_p.I418T|RTN2_ENST00000430715.2_Missense_Mutation_p.I151T O75298 RTN2_HUMAN reticulon 2 491 integral to endoplasmic reticulum membrane signal transducer activity cervix(1)|endometrium(2)|kidney(3)|large_intestine(2)|lung(6)|ovary(4)|skin(1)|urinary_tract(1) 20 Ovarian(192;0.051)|all_neural(266;0.112) OV - Ovarian serous cystadenocarcinoma(262;0.00829)|Epithelial(262;0.184)|GBM - Glioblastoma multiforme(486;0.246) CAGCAGGGGGATGGTGAATAG 0.582000 3 123 0 0 0.004672 0 0 MET 0 broad.mit.edu 37 7 116397529 116397529 + Missense_Mutation SNP T T C TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr7:116397529T>C ENST00000397752.3 + 7 2101 c.1901T>C c.(1900-1902)tTc>tCc p.F634S MET_ENST00000436117.2_Missense_Mutation_p.F634S|MET_ENST00000318493.6_Missense_Mutation_p.F634S NM_000245.2|NM_001127500.1 NP_000236.2|NP_001120972.1 P08581 MET_HUMAN met proto-oncogene 634 IPT/TIG 1. axon guidance|cell proliferation basal plasma membrane|integral to plasma membrane ATP binding|hepatocyte growth factor receptor activity|protein binding NS(10)|breast(4)|central_nervous_system(4)|endometrium(5)|haematopoietic_and_lymphoid_tissue(5)|kidney(25)|large_intestine(8)|liver(3)|lung(70)|ovary(10)|pleura(2)|prostate(4)|skin(5)|stomach(6)|testis(1)|thyroid(4)|upper_aerodigestive_tract(64)|urinary_tract(3) 233 all_cancers(3;1.25e-07)|all_epithelial(6;4.07e-08)|Lung NSC(10;0.00108)|all_lung(10;0.00125) Ovarian(593;0.133) GBM - Glioblastoma multiforme(2;2.31e-07)|all cancers(2;0.000419)|STAD - Stomach adenocarcinoma(10;0.000512) AATAAGCATTTCAATATGTCC 0.343000 Mis """papillary renal, head-neck squamous cell """ papillary renal Hereditary Papillary Renal Carcinoma (type 1) 48 58 0 0 0.014410 0 0 S1PR5 53637 broad.mit.edu 37 19 10624526 10624526 + Missense_Mutation SNP C C T TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr19:10624526C>T ENST00000439028.3 - 2 1287 c.1162G>A c.(1162-1164)Gcc>Acc p.A388T S1PR5_ENST00000333430.4_Missense_Mutation_p.A388T NM_001166215.1 NP_001159687.1 Q9H228 S1PR5_HUMAN sphingosine-1-phosphate receptor 5 388 integral to membrane|plasma membrane lysosphingolipid and lysophosphatidic acid receptor activity central_nervous_system(1)|endometrium(2)|large_intestine(1)|lung(5)|ovary(1)|pancreas(1)|prostate(1) 12 AGAGTCCGGGCGGCTGTGGGT 0.612000 12 91 0 0 0.010729 0 0 POTEC 388468 broad.mit.edu 37 18 14513734 14513734 + Missense_Mutation SNP C C T TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr18:14513734C>T ENST00000358970.5 - 10 1459 c.1460G>A c.(1459-1461)gGa>gAa p.G487E NM_001137671.1 NP_001131143.1 B2RU33 POTEC_HUMAN POTE ankyrin domain family, member C 487 p.G487E(2) NS(2)|breast(1)|endometrium(9)|kidney(13)|lung(14)|prostate(3)|skin(6)|soft_tissue(1)|urinary_tract(3) 52 TTGTGATATTCCAGTGTTCTG 0.323000 4 98 0 0 0.014758 0 0 SMAD5 4090 broad.mit.edu 37 5 135510116 135510116 + Missense_Mutation SNP A A G TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr5:135510116A>G ENST00000545279.1 + 7 1409 c.1049A>G c.(1048-1050)gAc>gGc p.D350G SMAD5_ENST00000545620.1_Missense_Mutation_p.D350G|SMAD5_ENST00000514641.2_3'UTR NM_001001419.1|NM_005903.5 NP_001001419.1|NP_005894.3 Q99717 SMAD5_HUMAN SMAD family member 5 350 MH2. BMP signaling pathway|embryonic pattern specification|positive regulation of transcription, DNA-dependent|transforming growth factor beta receptor signaling pathway cytosol|integral to membrane|transcription factor complex sequence-specific DNA binding transcription factor activity|transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity|ubiquitin protein ligase binding central_nervous_system(1)|large_intestine(4)|lung(3) 8 KIRC - Kidney renal clear cell carcinoma(527;0.0101)|Kidney(363;0.0233) TGCCTCAGTGACAGCAGCATA 0.418000 6 137 0 0 0.001168 0 0 KRTAP4-8 728224 broad.mit.edu 37 17 39253956 39253956 + Silent SNP G G A rs139720993 by1000genomes TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr17:39253956G>A ENST00000333822.4 - 1 437 c.381C>T c.(379-381)ccC>ccT p.P127P NM_031960.2 NP_114166.1 Q9BYQ9 KRA48_HUMAN keratin associated protein 4-8 127 25 X 5 AA repeats of C-C-[IKRQVHEC]- [SPRT]-[STCVQPR]. keratin filament p.P127P(1) endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|lung(1)|prostate(1) 11 tgctgcagctggggcggcagc 0.677000 5 25 0 0 0.008291 0 0 SULF1 23213 broad.mit.edu 37 8 70513977 70513977 + Missense_Mutation SNP G G C TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr8:70513977G>C ENST00000260128.4 + 10 1691 c.974G>C c.(973-975)gGa>gCa p.G325A SULF1_ENST00000458141.2_Missense_Mutation_p.G325A|SULF1_ENST00000419716.3_Missense_Mutation_p.G325A|SULF1_ENST00000402687.4_Missense_Mutation_p.G325A|SULF1_ENST00000521946.1_3'UTR NM_015170.2 NP_055985.2 Q8IWU6 SULF1_HUMAN sulfatase 1 325 apoptosis|bone development|heparan sulfate proteoglycan metabolic process|kidney development|negative regulation of fibroblast growth factor receptor signaling pathway cell surface|endoplasmic reticulum|extracellular space|Golgi stack arylsulfatase activity|calcium ion binding breast(2)|central_nervous_system(3)|endometrium(5)|kidney(3)|large_intestine(10)|lung(15)|ovary(3)|pancreas(2)|prostate(2)|skin(3)|upper_aerodigestive_tract(3)|urinary_tract(1) 52 Breast(64;0.0654) Epithelial(68;0.0124)|OV - Ovarian serous cystadenocarcinoma(28;0.0265)|all cancers(69;0.0534) GGGCAGTTTGGACTGGTCAAG 0.448000 9 258 0 0 0.004482 0 0 IDH1 3417 broad.mit.edu 37 2 209113112 209113112 + Missense_Mutation SNP C C T rs121913500 TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr2:209113112C>T ENST00000415913.1 - 4 776 c.395G>A c.(394-396)cGt>cAt p.R132H IDH1_ENST00000345146.2_Missense_Mutation_p.R132H|IDH1_ENST00000446179.1_Missense_Mutation_p.R132H O75874 IDHC_HUMAN isocitrate dehydrogenase 1 (NADP+), soluble 132 R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate). 2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle cytosol|peroxisomal matrix isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity p.R132H(2774)|p.R132L(59)|p.R132V(1)|p.G131_R132>VL(1) NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1) 4887 Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136) ATAAGCATGACGACCTATGAT 0.393000 Mis gliobastoma 23 53 0 0 0.018920 0 0 BPI 671 broad.mit.edu 37 20 36953197 36953197 + Nonsense_Mutation SNP C C T rs150749170 TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr20:36953197C>T ENST00000262865.4 + 9 1056 c.967C>T c.(967-969)Cga>Tga p.R323* BPI_ENST00000489102.1_3'UTR|CTD-2308N23.2_ENST00000437016.1_RNA NM_001725.2 NP_001716.2 P17213 BPI_HUMAN bactericidal/permeability-increasing protein 323 defense response to bacterium|negative regulation of interleukin-6 production|negative regulation of interleukin-8 production|negative regulation of macrophage activation|negative regulation of tumor necrosis factor production extracellular region|integral to plasma membrane lipid binding|lipopolysaccharide binding kidney(1)|large_intestine(6)|lung(15)|ovary(4)|prostate(2)|stomach(1)|urinary_tract(1) 30 Myeloproliferative disorder(115;0.00878) GTCCAAATTTCGACTGACAAC 0.512000 6 103 0 0 0.001984 0 0 FYB 2533 broad.mit.edu 37 5 39126188 39126188 + Silent SNP A A G TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr5:39126188A>G ENST00000505428.1 - 12 2114 c.1957T>C c.(1957-1959)Ttg>Ctg p.L653L FYB_ENST00000540520.1_Silent_p.L663L|FYB_ENST00000512982.1_Silent_p.L653L|FYB_ENST00000351578.6_Intron|FYB_ENST00000515010.1_Intron NM_001465.4 NP_001456.3 O15117 FYB_HUMAN FYN binding protein 636 cell junction assembly|immune response|intracellular protein kinase cascade|NLS-bearing substrate import into nucleus|protein phosphorylation|T cell receptor signaling pathway cytosol|nucleus protein binding endometrium(2)|kidney(4)|large_intestine(6)|liver(1)|lung(29)|ovary(2)|upper_aerodigestive_tract(1) 45 all_lung(31;0.000343) Epithelial(62;0.235) AACATCTTCAAAATCCCCCAG 0.408000 24 29 0 0 0.004656 0 0 OR2H2 7932 broad.mit.edu 37 6 29556539 29556539 + Missense_Mutation SNP G G C TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr6:29556539G>C ENST00000383640.2 + 1 857 c.818G>C c.(817-819)gGt>gCt p.G273A GABBR1_ENST00000355973.3_Intron NM_007160.3 NP_009091.3 O95918 OR2H2_HUMAN olfactory receptor, family 2, subfamily H, member 2 273 defense response|mating|sensory perception of smell integral to membrane|plasma membrane olfactory receptor activity central_nervous_system(1)|kidney(1)|large_intestine(3)|lung(7)|prostate(1)|urinary_tract(1) 14 AAGTTCTTTGGTCTCTTCTAT 0.512000 4 75 0 0 0.009096 0 0 MDC1 9656 broad.mit.edu 37 6 30679448 30679448 + Silent SNP C C T TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr6:30679448C>T ENST00000376406.3 - 6 2771 c.2124G>A c.(2122-2124)ctG>ctA p.L708L MDC1_ENST00000494654.1_5'UTR|MDC1_ENST00000376405.2_Silent_p.L708L|MDC1-AS1_ENST00000442150.1_RNA NM_014641.2 NP_055456.2 Q14676 MDC1_HUMAN mediator of DNA-damage checkpoint 1 708 Missing (in Ref. 2; CAH18685). cell cycle|double-strand break repair via homologous recombination|intra-S DNA damage checkpoint focal adhesion|nucleoplasm FHA domain binding|protein C-terminus binding breast(2)|kidney(1)|ovary(1) 4 CCTCACCTTCCAGGCCCTGAT 0.468000 Other conserved DNA damage response genes 6 131 0 0 0.004482 0 0 BAGE2 85319 broad.mit.edu 37 21 11038917 11038917 + RNA SNP A A G TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr21:11038917A>G ENST00000470054.1 - 0 1286 B melanoma antigen family, member 2 Colorectal(6;3.44e-05)|COAD - Colon adenocarcinoma(6;0.00727)|READ - Rectum adenocarcinoma(6;0.0723) UCEC - Uterine corpus endometrioid carcinoma (6;0.0974)|all cancers(6;2.54e-22)|Epithelial(6;4.21e-19)|OV - Ovarian serous cystadenocarcinoma(6;1.16e-09)|BRCA - Breast invasive adenocarcinoma(6;7.72e-05)|Lung(8;0.000189)|LUSC - Lung squamous cell carcinoma(6;0.00379)|GBM - Glioblastoma multiforme(6;0.00391)|Kidney(17;0.0773)|LUAD - Lung adenocarcinoma(8;0.247) GGGGAGGAAGACACATCTGCC 0.428000 40 604 0 0 0.007835 0 0 ATRX 546 broad.mit.edu 37 X 76912104 76912104 + Nonsense_Mutation SNP G G C TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chrX:76912104G>C ENST00000373344.5 - 13 4374 c.4160C>G c.(4159-4161)tCa>tGa p.S1387* ATRX_ENST00000480283.1_5'UTR|ATRX_ENST00000395603.3_Nonsense_Mutation_p.S1349* NM_000489.3 NP_000480.2 P46100 ATRX_HUMAN alpha thalassemia/mental retardation syndrome X-linked 1387 DNA methylation|DNA recombination|DNA repair|regulation of transcription, DNA-dependent nuclear heterochromatin ATP binding|chromo shadow domain binding|DNA binding|DNA helicase activity|zinc ion binding p.?(1) bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2) 145 Phosphatidylserine(DB00144) ACTAACTCCTGATTCCTGAAA 0.284000 """Mis, F, N""" """Pancreatic neuroendocrine tumors, paediatric GBM""" ATR-X (alpha thalassemia/mental retardation) syndrome 23 14 0 0 0.021523 0 0 CLN8 2055 broad.mit.edu 37 8 1719509 1719509 + Missense_Mutation SNP C C T TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr8:1719509C>T ENST00000331222.4 + 2 536 c.289C>T c.(289-291)Cgt>Tgt p.R97C NM_018941.3 NP_061764.2 Q9UBY8 CLN8_HUMAN ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) 97 TLC. cell death|ceramide biosynthetic process|cholesterol metabolic process|lipid transport|negative regulation of proteolysis|phospholipid metabolic process endoplasmic reticulum membrane|ER-Golgi intermediate compartment membrane|integral to membrane central_nervous_system(1)|endometrium(3)|kidney(4)|large_intestine(4)|lung(7)|ovary(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(2) 24 Ovarian(12;0.0563)|Colorectal(14;0.0815)|Hepatocellular(245;0.0831) BRCA - Breast invasive adenocarcinoma(11;7.67e-05)|READ - Rectum adenocarcinoma(644;0.0913) CGACAAGGCGCGTGGCCAGCA 0.592000 4 108 0 0 0.009096 0 0 CTAGE1 64693 broad.mit.edu 37 18 19996739 19996739 + Nonsense_Mutation SNP G G A TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr18:19996739G>A ENST00000391403.2 - 1 1139 c.1036C>T c.(1036-1038)Cag>Tag p.Q346* NM_172241.2 NP_758441.2 Q96RT6 CTGE2_HUMAN cutaneous T-cell lymphoma-associated antigen 1 346 integral to membrane cervix(1)|endometrium(2)|kidney(3)|large_intestine(1)|lung(19)|ovary(1) 27 all_cancers(21;0.000361)|all_epithelial(16;9.61e-06)|Colorectal(14;0.0533)|Lung NSC(20;0.0605)|Ovarian(2;0.116)|all_lung(20;0.135) TGAAGCTTCTGATTCTCACTT 0.323000 4 90 0 0 0.001168 0 0 SGCA 6442 broad.mit.edu 37 17 48246530 48246530 + Missense_Mutation SNP G G A rs138254713 by1000genomes TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr17:48246530G>A ENST00000262018.3 + 6 698 c.662G>A c.(661-663)cGc>cAc p.R221H SGCA_ENST00000513942.1_Intron|SGCA_ENST00000543315.1_Intron|SGCA_ENST00000344627.6_Intron|SGCA_ENST00000451235.2_Missense_Mutation_p.R119H NM_000023.2 NP_000014.1 Q16586 SGCA_HUMAN sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) 221 muscle contraction|muscle organ development cytoplasm|cytoskeleton|integral to membrane|sarcoglycan complex|sarcolemma calcium ion binding breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|lung(7)|ovary(2)|skin(1) 14 AGCCACGCCCGCTGTGCCCAG 0.577000 OREG0024558 type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip) 45 55 0 0 0.010771 0 0 GRIN2A 0 broad.mit.edu 37 16 9857957 9857957 + Silent SNP C C T TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr16:9857957C>T ENST00000396573.2 - 14 3753 c.3444G>A c.(3442-3444)ccG>ccA p.P1148P GRIN2A_ENST00000535259.1_Silent_p.P991P|GRIN2A_ENST00000562109.1_Silent_p.P1148P|GRIN2A_ENST00000404927.2_Silent_p.P1148P|GRIN2A_ENST00000330684.3_Silent_p.P1148P|GRIN2A_ENST00000396575.2_Silent_p.P1148P NM_000833.3 NP_000824.1 Q12879 NMDE1_HUMAN glutamate receptor, ionotropic, N-methyl D-aspartate 2A 1148 response to ethanol cell junction|N-methyl-D-aspartate selective glutamate receptor complex|outer membrane-bounded periplasmic space|postsynaptic membrane N-methyl-D-aspartate selective glutamate receptor activity|zinc ion binding NS(7)|breast(5)|cervix(1)|endometrium(11)|kidney(6)|large_intestine(36)|lung(71)|ovary(4)|prostate(9)|skin(45)|upper_aerodigestive_tract(2)|urinary_tract(1) 198 Felbamate(DB00949)|Glycine(DB00145)|L-Glutamic Acid(DB00142)|Loperamide(DB00836)|Memantine(DB01043) GGTAGGGGTCCGGGAAGTCCA 0.527000 5 213 0 0 0.014758 0 0 KMT2C 58508 broad.mit.edu 37 7 151945175 151945175 + Missense_Mutation SNP A A G TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr7:151945175A>G ENST00000355193.2 - 14 2562 c.2344T>C c.(2344-2346)Tct>Cct p.S782P KMT2C_ENST00000262189.6_Missense_Mutation_p.S782P lysine (K)-specific methyltransferase 2C GGGGAGGAAGACACATCTGCC 0.428000 11 498 0 0 0.012319 0 0 PLCB1 23236 broad.mit.edu 37 20 8665706 8665706 + Silent SNP G G A TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr20:8665706G>A ENST00000378641.3 + 10 1465 c.990G>A c.(988-990)tcG>tcA p.S330S PLCB1_ENST00000338037.6_Silent_p.S330S|PLCB1_ENST00000378637.2_Silent_p.S330S NM_182734.1 NP_877398.1 Q9NQ66 PLCB1_HUMAN phospholipase C, beta 1 (phosphoinositide-specific) 330 PI-PLC X-box. activation of meiosis involved in egg activation|CD24 biosynthetic process|cerebral cortex development|G1 phase|G2/M transition of mitotic cell cycle|glutamate signaling pathway|insulin-like growth factor receptor signaling pathway|interleukin-1-mediated signaling pathway|interleukin-12-mediated signaling pathway|interleukin-15-mediated signaling pathway|intracellular signal transduction|lipid catabolic process|memory|muscarinic acetylcholine receptor signaling pathway|negative regulation of monocyte extravasation|negative regulation of transcription, DNA-dependent|phosphatidylinositol metabolic process|positive regulation of acrosome reaction|positive regulation of developmental growth|positive regulation of embryonic development|positive regulation of interleukin-12 production|positive regulation of JNK cascade|positive regulation of myoblast differentiation|positive regulation of transcription, DNA-dependent|regulation of fertilization|regulation of G-protein coupled receptor protein signaling pathway|synaptic transmission cytosol|nuclear chromatin|nuclear speck calcium ion binding|calmodulin binding|enzyme binding|GTPase activator activity|phosphatidylinositol phospholipase C activity|phosphatidylinositol-4,5-bisphosphate binding|protein homodimerization activity|signal transducer activity NS(2)|breast(3)|endometrium(5)|haematopoietic_and_lymphoid_tissue(3)|kidney(1)|large_intestine(11)|liver(2)|lung(41)|ovary(4)|prostate(3)|skin(12)|stomach(1)|upper_aerodigestive_tract(3)|urinary_tract(4) 95 TTAATTCCTCGCACAACACCT 0.418000 12 156 0 0 0.016723 0 0 ANTXR1 84168 broad.mit.edu 37 2 69329991 69329991 + Missense_Mutation SNP G G A TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr2:69329991G>A ENST00000303714.4 + 10 1043 c.721G>A c.(721-723)Gtg>Atg p.V241M ANTXR1_ENST00000409829.3_Missense_Mutation_p.V241M|ANTXR1_ENST00000409349.3_Missense_Mutation_p.V241M NM_032208.2 NP_115584.1 Q9H6X2 ANTR1_HUMAN anthrax toxin receptor 1 241 actin cytoskeleton reorganization|substrate adhesion-dependent cell spreading filopodium membrane|integral to membrane|lamellipodium membrane actin filament binding|collagen binding|metal ion binding|protein binding|transmembrane receptor activity haematopoietic_and_lymphoid_tissue(1)|large_intestine(5)|lung(16)|ovary(2)|skin(3)|stomach(1)|upper_aerodigestive_tract(1) 29 TCAAGTTGTCGTGAGAGGAAA 0.473000 Familial Infantile Hemangioma 25 359 0 0 0.006320 0 0 TSHZ1 10194 broad.mit.edu 37 18 72998072 72998072 + Missense_Mutation SNP G G A TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr18:72998072G>A ENST00000322038.5 + 2 1159 c.575G>A c.(574-576)gGc>gAc p.G192D TSHZ1_ENST00000580243.1_Missense_Mutation_p.G237D NM_005786.5 NP_005777.3 Q6ZSZ6 TSH1_HUMAN teashirt zinc finger homeobox 1 237 Ser-rich. nucleus sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding NS(1)|breast(2)|central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(11)|liver(1)|lung(14)|ovary(1)|skin(6)|upper_aerodigestive_tract(2) 42 Esophageal squamous(42;0.129)|Prostate(75;0.142)|Melanoma(33;0.211) Colorectal(1;0.000501)|READ - Rectum adenocarcinoma(2;0.00226)|BRCA - Breast invasive adenocarcinoma(31;0.246) AAGCTCTACGGCTCCGTCTTC 0.617000 5 50 0 0 0.001984 0 0 KIF23 9493 broad.mit.edu 37 15 69714351 69714351 + Missense_Mutation SNP G G A TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr15:69714351G>A ENST00000260363.4 + 5 454 c.337G>A c.(337-339)Gtg>Atg p.V113M KIF23_ENST00000352331.4_Missense_Mutation_p.V113M|KIF23_ENST00000559279.1_Missense_Mutation_p.V113M|KIF23_ENST00000395392.2_Missense_Mutation_p.V113M NM_138555.2 NP_612565.1 Q02241 KIF23_HUMAN kinesin family member 23 113 Kinesin-motor. blood coagulation|cytokinesis|microtubule-based movement|mitosis|mitotic spindle elongation cytosol|kinesin complex|microtubule|midbody|nucleoplasm|spindle ATP binding|microtubule motor activity|protein binding central_nervous_system(1)|endometrium(4)|large_intestine(7)|lung(6)|prostate(2)|skin(1) 21 TACATATGGTGTGACGGGAAG 0.408000 6 51 0 0 0.001168 0 0 SLC47A2 146802 broad.mit.edu 37 17 19606453 19606453 + Missense_Mutation SNP A A G TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr17:19606453A>G ENST00000350657.5 - 13 1262 c.1088T>C c.(1087-1089)cTg>cCg p.L363P SLC47A2_ENST00000463318.1_Intron|SLC47A2_ENST00000325411.5_Missense_Mutation_p.L385P NM_001099646.1|NM_001256663.1 NP_001093116.1|NP_001243592.1 Q86VL8 S47A2_HUMAN solute carrier family 47 (multidrug and toxin extrusion), member 2 385 integral to membrane|plasma membrane drug:hydrogen antiporter activity endometrium(2)|kidney(3)|large_intestine(2)|lung(1)|ovary(1) 9 all_cancers(12;2.3e-05)|all_epithelial(12;0.0024)|Breast(13;0.245) GATGCTTATCAGGGTGCCCAG 0.483000 3 48 0 0 0.009096 0 0 CA1 759 broad.mit.edu 37 8 86244738 86244738 + Missense_Mutation SNP A A G TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr8:86244738A>G ENST00000523953.1 - 7 1540 c.494T>C c.(493-495)cTc>cCc p.L165P CA1_ENST00000256119.5_Missense_Mutation_p.L165P|CA1_ENST00000542576.1_Missense_Mutation_p.L165P|CA1_ENST00000523022.1_Missense_Mutation_p.L165P|CA1_ENST00000432364.2_Missense_Mutation_p.L165P|CA1_ENST00000522389.1_Intron|CA1_ENST00000431316.1_Missense_Mutation_p.L165P P00915 CAH1_HUMAN carbonic anhydrase I 165 one-carbon metabolic process Golgi apparatus carbonate dehydratase activity|zinc ion binding breast(1)|central_nervous_system(1)|endometrium(3)|kidney(1)|large_intestine(1)|lung(4)|ovary(1)|prostate(1) 13 all_lung(136;4.89e-06) Acetazolamide(DB00819)|Amlodipine(DB00381)|Bendroflumethiazide(DB00436)|Benzthiazide(DB00562)|Brinzolamide(DB01194)|Chlorothiazide(DB00880)|Cyclothiazide(DB00606)|Diazoxide(DB01119)|Dichlorphenamide(DB01144)|Ethinamate(DB01031)|Ethoxzolamide(DB00311)|Hydrochlorothiazide(DB00999)|Hydroflumethiazide(DB00774)|Levetiracetam(DB01202)|Methazolamide(DB00703)|Methyclothiazide(DB00232)|Quinethazone(DB01325)|Trichlormethiazide(DB01021)|Verapamil(DB00661)|Zonisamide(DB00909) AATTGCTTGGAGGGCATCAAG 0.328000 28 31 0 0 0.017118 0 0 KATNA1 11104 broad.mit.edu 37 6 149959574 149959574 + Frame_Shift_Del DEL T T - TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr6:149959574delT ENST00000367411.2 - 2 368 c.110delA c.(109-111)acfs p.N37fs KATNA1_ENST00000335643.8_Frame_Shift_Del_p.N37fs|KATNA1_ENST00000335647.5_Frame_Shift_Del_p.N37fs NM_007044.3 NP_008975.1 O75449 KTNA1_HUMAN katanin p60 (ATPase containing) subunit A 1 37 Interaction with microtubule. cell division|interphase of mitotic cell cycle|mitosis microtubule|microtubule organizing center|spindle pole ATP binding|microtubule binding|microtubule-severing ATPase activity|protein heterodimerization activity endometrium(1)|kidney(1)|large_intestine(2)|lung(5)|ovary(1)|skin(1)|urinary_tract(1) 12 Ovarian(120;0.0164) OV - Ovarian serous cystadenocarcinoma(155;2.95e-12)|GBM - Glioblastoma multiforme(68;0.173) CAGATACTTGTTCATTTGGTC 0.403 78 197 --- --- --- --- COL26A1 136227 broad.mit.edu 37 7 101193885 101193885 + RNA DEL C C - rs78938234 TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr7:101193885delC ENST00000313669.7 + 0 1185 COL26A1_ENST00000397927.3_RNA|COL26A1_ENST00000528707.1_RNA NM_133457.2 NP_597714.2 collagen, type XXVI, alpha 1 gctgggaggaccagggaggca 0.597 3 4 --- --- --- --- CTRL 1506 broad.mit.edu 37 16 67963919 67963919 + Frame_Shift_Del DEL T T - TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr16:67963919delT ENST00000574481.1 - 7 1274 c.713delA c.(712-714)acfs p.N238fs NM_001907.2 NP_001898.1 P40313 CTRL_HUMAN chymotrypsin-like 238 Peptidase S1. digestion|proteolysis extracellular space serine-type endopeptidase activity kidney(1)|large_intestine(2)|urinary_tract(1) 4 Ovarian(137;0.192) OV - Ovarian serous cystadenocarcinoma(108;0.00412)|Epithelial(162;0.018)|all cancers(182;0.118) CACATTGCAGTTTTTGGTGCC 0.552 8 268 --- --- --- --- TP53 7157 broad.mit.edu 37 17 7579346 7579348 + In_Frame_Del DEL AAG AAG - TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr17:7579346_7579348delAAG ENST00000420246.2 - 4 471_473 c.339_341delCTT c.(337-342)ttg>tt p.FL113del TP53_ENST00000269305.4_In_Frame_Del_p.FL113del|TP53_ENST00000359597.4_In_Frame_Del_p.FL113del|TP53_ENST00000455263.2_In_Frame_Del_p.FL113del|TP53_ENST00000413465.2_In_Frame_Del_p.FL113del|TP53_ENST00000445888.2_In_Frame_Del_p.FL113del NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 113 Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42. F -> C (in sporadic cancers; somatic mutation).|F -> G (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).|F -> I (in a sporadic cancer; somatic mutation).|F -> L (in sporadic cancers; somatic mutation).|F -> S (in sporadic cancers; somatic mutation).|F -> V (in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.0?(8)|p.L114*(4)|p.F113L(3)|p.G59fs*23(3)|p.F113C(2)|p.F113del(2)|p.V73fs*9(1)|p.G105_T125del21(1)|p.G112_V122delGFLHSGTAKSV(1)|p.G112fs*9(1)|p.Y107fs*44(1)|p.G112_S116delGFLHS(1)|p.P13fs*18(1)|p.S33fs*23(1)|p.L114fs*30(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) CCCAGAATGCAAGAAGCCCAGAC 0.601 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 31 79 --- --- --- --- TP53 7157 broad.mit.edu 37 17 7579589 7579590 + Splice_Site INS - - A TCGA-FG-6689-01A-11D-1893-08 TCGA-FG-6689-10A-01D-1893-08 Untested Somatic Phase_I WXS none Illumina GAIIx 00580e36-eea0-455e-90e7-f5ee7bd1cd7b 622315d2-4383-4daa-bbe1-6c1441db2ff8 g.chr17:7579589_7579590insA ENST00000420246.2 - 4 229_230 c.96_splice c.e4-1 p.P33_splice TP53_ENST00000269305.4_Splice_Site_p.P33_splice|TP53_ENST00000359597.4_Splice_Site_p.P33_splice|TP53_ENST00000455263.2_Splice_Site_p.P33_splice|TP53_ENST00000413465.2_Splice_Site_p.P33_splice|TP53_ENST00000445888.2_Splice_Site_p.P33_splice NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 33 Interaction with HRMT1L2.|Transcription activation (acidic). S -> T (in a sporadic cancer; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.0?(8)|p.L35fs*10(3)|p.L35fs*9(2)|p.?(1)|p.S33fs*23(1)|p.S33fs*11(1)|p.S33fs*10(1)|p.S33T(1)|p.P13fs*18(1)|p.S33fs*6(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) CGGCAAGGGGGACTGTAGATGG 0.594 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 132 228 --- --- --- ---